University of Leeds and Freeline Therapeutics Limited
Lead Participant:
UNIVERSITY OF LEEDS
Abstract
To introduce advanced computational techniques and develop a new platform to accelerate discovery of novel and effective gene therapies to treat currently incurable diseases. To deliver new treatments faster and in a cost-effective manner.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
UNIVERSITY OF LEEDS | £327,348 | £ 219,323 |
  | ||
Participant |
||
FREELINE THERAPEUTICS LIMITED | ||
THE UNIVERSITY OF LEEDS |
People |
ORCID iD |